Median Diagnostics Inc. Logo

Median Diagnostics Inc.

Manufactures veterinary IVD kits & raw materials to diagnose infectious animal diseases.

233250 | KO

Overview

Corporate Details

ISIN(s):
KR7233250000
LEI:
Country:
South Korea
Address:
강원도 춘천시 동내면 순환대로 878, 춘천시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Median Diagnostics Inc. is a developer and manufacturer specializing in in-vitro diagnostic (IVD) solutions for veterinary use. The company produces a comprehensive portfolio of products including PCR, ELISA, and rapid test kits, along with standard reagents and biological raw materials like monoclonal antibodies and antigens. These products are designed for the early diagnosis and monitoring of high-consequence infectious animal diseases, such as African Swine Fever (ASF), Foot-and-Mouth Disease (FMD), and Avian Influenza (AI). While its focus is veterinary, the company also supplies raw materials for human disease diagnosis. Median Diagnostics operates under a "One Health" philosophy, aiming to provide total diagnostic systems that are Speedy, Measurable, Accurate, and Reasonable (S.M.A.R.T.).

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-03-19 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 16.2 KB
2025-03-11 00:00
Audit Report / Information
감사보고서제출
Korean 15.9 KB
2025-03-11 00:00
Annual / Quarterly Financial Statement
사업보고서 (2024.12)
Korean 377.2 KB
2025-03-07 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 89.7 KB
2025-03-07 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-03-04 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 131.2 KB
2025-02-19 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 7.3 KB
2025-01-21 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 79.6 KB
2025-01-21 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.6 KB
2025-01-09 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 80.2 KB
2025-01-09 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.6 KB
2025-01-08 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.6 KB
2024-12-23 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.6 KB
2024-12-20 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 82.5 KB
2024-12-20 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB

Automate Your Workflow. Get a real-time feed of all Median Diagnostics Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Median Diagnostics Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Median Diagnostics Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

REGENXBIO Inc. Logo
Developing AAV gene therapies for retinal, metabolic, and neurodegenerative diseases.
United States of America
RGNX
Rein Therapeutics, Inc. Logo
Clinical-stage biopharma developing novel therapies for orphan pulmonary diseases and fibrosis.
United States of America
RNTX
Rekah Pharmaceutical Prod Ltd. Logo
A full-service generic pharma manufacturer of drugs, devices, and supplements for global markets.
Israel
REKA
Relay Therapeutics, Inc. Logo
Developing precision medicines for oncology & genetic diseases by analyzing protein motion.
United States of America
RLAY
Repare Therapeutics Inc. Logo
Develops precision oncology drugs using a CRISPR platform for cancers with genomic instabilities.
United States of America
RPTX
Replek AD Logo
Manufactures & distributes generic medicines, supplements, and cosmetic products to over 25 countries.
North Macedonia
REPL
Respiratorius AB Logo
Develops oncology pre-treatment drugs to enhance the efficacy of standard cancer therapies.
Sweden
RESP
REVELATION BIOSCIENCES, INC. Logo
Develops therapies that reprogram the innate immune system to reduce inflammation-related damage.
United States of America
REVB
REVIVA PHARMACEUTICALS HOLDINGS, INC. Logo
Clinical-stage biopharma developing novel therapies for CNS, respiratory, and metabolic diseases.
United States of America
RVPH
Revolution Medicines, Inc. Logo
A clinical-stage oncology company developing targeted therapies for RAS-addicted cancers.
United States of America
RVMD

Talk to a Data Expert

Have a question? We'll get back to you promptly.